Abediterol (LAS100977), an inhaled long-acting β 2 -adrenoceptor agonist, has a fast association rate and long residence time at receptor
Abstract
This study describes the association rate and residence time of abediterol, a novel long-acting β2-adrenoceptor agonist (LABA) in Phase II development for treatment of asthma and COPD, in comparison with indacaterol, olodaterol, vilanterol and salmeterol, for both human β1- and β2-adrenoceptors. Abediterol association and dissociation rates were monitored directly by using its tritiated form. Moreover, association was determined indirectly using...
Paper Details
Title
Abediterol (LAS100977), an inhaled long-acting β 2 -adrenoceptor agonist, has a fast association rate and long residence time at receptor
Published Date
Jan 1, 2018
Volume
819
Pages
89 - 97
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History